IQVIA
IQV
#585
Rank
NZ$76.22 B
Marketcap
NZ$463.08
Share price
0.39%
Change (1 day)
33.74%
Change (1 year)

Earnings for IQVIA (IQV)

Earnings in 2026 (TTM): NZ$4.07 Billion

According to IQVIA's latest financial reports the company's current earnings are NZ$16.98 Billion. In 2025 the company made an earning of NZ$4.13 Billion a decrease over its 2024 earnings that were of NZ$4.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for IQVIA from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$4.07 B-1.52%
2025 NZ$4.13 B-0.81%
2024 NZ$4.16 B9.76%
2023 NZ$3.79 B19.79%
2022 NZ$3.17 B18.36%
2021 NZ$2.67 B90.49%
2020 NZ$1.40 B-1.25%
2019 NZ$1.42 B7.68%
2018 NZ$1.32 B6.61%
2017 NZ$1.24 B11.74%
2016 NZ$1.10 B-2.79%
2015 NZ$1.14 B6.31%
2014 NZ$1.07 B34.96%
2013 NZ$0.79 B11.16%
2012 NZ$0.71 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-NZ$3.86 Million-100.09% Bahamas
NRC Health
NRC
NZ$26.35 M-99.37%๐Ÿ‡บ๐Ÿ‡ธ USA